Last CNY44.50 CNY
Change Today -1.03 / -2.26%
Volume 3.2M
002252 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

shanghai raas blood produc-a (002252) Snapshot

Open
CNY45.55
Previous Close
CNY45.53
Day High
CNY46.09
Day Low
CNY44.50
52 Week High
10/30/14 - CNY51.00
52 Week Low
01/21/14 - CNY21.70
Market Cap
54.4B
Average Volume 10 Days
3.6M
EPS TTM
CNY0.27
Shares Outstanding
1.2B
EX-Date
04/24/14
P/E TM
167.6x
Dividend
CNY0.05
Dividend Yield
0.11%
Current Stock Chart for SHANGHAI RAAS BLOOD PRODUC-A (002252)

Related News

No related news articles were found.

shanghai raas blood produc-a (002252) Related Businessweek News

No Related Businessweek News Found

shanghai raas blood produc-a (002252) Details

Shanghai RAAS Blood Products Co., Ltd. is engaged in the research, development, manufacture, and distribution of blood products. The company’s blood products include human serum albumin, intravenous human immunoglobulin (pH4), human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, lyophilized human thrombin, and topical lyophilized fibrin adhesive. It also offers vaccines, diagnostic reagents, testing equipment, and detection technology, as well as provides testing services. The company is based in Shanghai, the People’s Republic of China.

shanghai raas blood produc-a (002252) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shanghai raas blood produc-a (002252) Key Developments

Shanghai RAAS Blood Products Co., Ltd. Approves Amendments to the Articles of Association

Shanghai RAAS Blood Products Co., Ltd. at its Extraordinary General Meeting to be held on November 14, 2014, will approved the amendments to the company's articles of association.

Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the Nine Months of 2014; Revises Earnings Guidance for the Year 2014

Shanghai RAAS Blood Products Co., Ltd. reported earnings results for the nine months of 2014. For the period, the company reported operating revenue of CNY 826 million, rising 78.44% from a year earlier. Net profit reached CNY 319 million, leaping 115.09%. Basic EPS were CNY 0.267. The company expected net profit to jump 220% to 250% to CNY 460.13 million to CNY 503.27 million in 2014 full year.

Shanghai RAAS Blood Products Co., Ltd. Proposes Amendments to the Articles of Association

Shanghai RAAS Blood Products Co., Ltd. at its Extraordinary General Meeting to be held on November 14, 2014, will approve the amendments to the company's articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002252:CH CNY44.50 CNY -1.03

002252 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Beijing Tiantan Biological Products Corp Ltd CNY28.18 CNY -0.52
China Biologic Products Inc $67.14 USD +1.30
Hualan Biological Engineering Inc CNY34.23 CNY -0.83
Jiangxi Boya Bio-Pharmaceutical Co Ltd CNY65.47 CNY -2.03
View Industry Companies
 

Industry Analysis

002252

Industry Average

Valuation 002252 Industry Range
Price/Earnings 100.0x
Price/Sales 62.5x
Price/Book 14.7x
Price/Cash Flow 170.7x
TEV/Sales 61.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI RAAS BLOOD PRODUC-A, please visit www.raas-corp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.